Arbidol for preventing and treating influenza in adults and children

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 1, 2015, Pages

  Huang, Liang ^a,b   Zhang, Lingli ^a,b   Liu, Yantao ^a,b   Luo, Rong ^a,b   Zeng, Linan ^a,b   Telegina, Irina ^c   Vlassov, Vasiliy V ^d  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c STAVROPOL STATE MEDICAL UNIVERSITY   (Russian Federation)

^d NATIONAL RESEARCH UNIVERSITY HIGHER SCHOOL OF ECONOMICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARBIDOL;

ANTIVIRAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL PROTOCOL; DERMATITIS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; LIVER TOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

EID: 85008258052     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011489     Document Type: Article

References (27)

1. Fior AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al.Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009;58:1-52.
2. Boriskin YS, Leneva IA, Pecheur EI, Polyak SJ. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Current Medicinal Chemistry 2008;15(10):997-1005.
3. US Centers for Disease Control and Prevention. Influenza activity - United States and worldwide, June 13 - September 25, 2010. Morbidity and Mortality Weekly Report 2010;59:1270-3.
4. De Clercq E. Antiviral agents active against influenza A viruses. Nature Review 2006;5:1015-25.
5. Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD001269.pub5]
6. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. 8. McGraw-Hill Companies, 2011.
7. Gagarinova VM, Ignat'eva GS, Sinitskaia LV, Ivanova AM, Rodina MA, Tur'eva AV. The new chemical preparation arbidol: its prophylactic efficacy during influenza epidemics. Zhural Mikrobiologii Epidemiologii I Immunobiologii 1993;5:40-3.
8. Galvão MGA, Santos MARC, Cunha AJA. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD002745.pub3]
9. Glushkov RG, Gus'kova TA, Krylova LIu, Nikolaeva IS. Mechanisms of arbidol's immunomodulating action. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1999;3:36-40.
10. Higgins JPT, Deeks JJ, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
11. Higgins JPT, Altman DG, Sterne JAC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
12. IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Medical Research Methodology 2014;14:25. [DOI: 10.1186/1471-2288-14-25]
13. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD004876.pub3]
14. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD001169.pub3]
15. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD004879.pub4]
16. Jefferson T, Jones MA, Doshi P, Mar CBD, Hama R, Thompson MJ, et al.Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD008965.pub4]
17. Jiang LH, Deng LY, Wu TX. Chinese medicinal herbs for influenza. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD004559.pub4]
18. Kingyee Company. Instructions for Arbidol Hydrochloride Granules (Zhuang Tong) approved by China Food and Drug Administration. 1.8. Kingyee Company, 2006.
19. Leneva IA, Russell RJ, Yury S, Boriskin YS, Hay AJ. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Research 2009;81:132-40.
20. Leneva IA, Fediakina IT, Eropkin MIu, Gudova NV, Romanovskaia AA, Danilenko DM, et al.Study of the antiviral activity of Russian anti influenza agents in cell culture and animal models. Voprosy Virusologii 2010;55(3):19-27.
21. Masterlek company. Instructions for the Medical Use of Arbidol-Manufactured 8 April 2005 by order of the Federal Supervisory Organization of Health and Welfare. http://arbidol.org/instructions-for=arbidol.pdf (accessed 27 October 2014) 2005.
22. Meanwell NA, Krystal M. Taking aim at a moving target: inhibitors of influenza virus. I. Virus adsorption, entry and uncoating. Drug Discovery Today 1996;1(8):1316-24.
23. Ohmit SE, Arden NH, Monto AS. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. Journal of the American Geriatrics Society 1999;47:165-71.
24. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
25. Stedman MR, Curtin F, Elbourne DR, Kesselheim AS, Brookhart MA. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2011;40(6):1732-4.
26. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002744.pub4]
27. World Health Organization. Influenza (seasonal). http://www.who.int/mediacentre/factsheets/fs211/en/ (accessed 17 April 2014) 2014.